|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics. 2013 CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. 2015 CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Simard EP, Dorell C, Noone AM,
Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, et
al: Annual Report to the Nation on the Status of Cancer 1975–2009,
featuring the burden and trends in human papillomavirus
(HPV)-associated cancers and HPV vaccination coverage levels. J
Natl Cancer Inst. 105:175–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kohler BA, Ward E, McCarthy BJ, Schymura
MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA and Edwards
BK: Annual Report to the Nation on the Status of Cancer, 1975–2007,
featuring tumors of the brain and other nervous system. J Natl
Cancer Inst. 103:714–736. 2011.PubMed/NCBI
|
|
6
|
Singh AB, Sharma A and Dhawan P: Claudin
family of proteins and cancer: An overview. J Oncol.
2010:5419572010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Furuse M, Fujita K, Hiiragi T, Fujimoto K
and Tsukita S: Claudin-1 and −2: Novel integral membrane proteins
localizing at tight junctions with no sequence similarity to
occludin. J Cell Biol. 141:1539–1550. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rahner C, Mitic LL and Anderson JM:
Heterogeneity in expression and subcellular localization of
claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut.
Gastroenterology. 120:411–422. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kyuno D, Yamaguchi H, Ito T, Kono T,
Kimura Y, Imamura M, Konno T, Hirata K, Sawada N and Kojima T:
Targeting tight junctions during epithelial to mesenchymal
transition in human pancreatic cancer. World J Gastroenterol.
20:10813–10824. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisenhauer EA, Therasse P, Bogaerts J, et
al: New response evaluation criteria in solid tumours: revised
RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan AT and Giovannucci EL: Primary
prevention of colorectal cancer. Gastroenterology.
138:2029–2043.e10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moon BS, Jeong WJ, Park J, Kim TI, Min S
and Choi KY: Role of oncogenic K-Ras in cancer stem cell activation
by aberrant Wnt/β-catenin signaling. J Natl Cancer Inst.
106:djt3732014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei EK, Giovannucci E, Wu K, Rosner B,
Fuchs CS, Willett WC and Colditz GA: Comparison of risk factors for
colon and rectal cancer. Int J Cancer. 108:433–442. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Süren D, Yıldırım M, Kaya V, Alikanoğlu
AS, Bülbüller N, Yıldız M and Sezer C: Loss of tight junction
proteins (claudin 1, 4 and 7) correlates with aggressive behavior
in colorectal carcinoma. Med Sci Monit. 20:1255–1262. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michl P, Barth C, Buchholz M, Lerch MM,
Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, et al:
Claudin-4 expression decreases invasiveness and metastatic
potential of pancreatic cancer. Cancer Res. 63:6265–6271.
2003.PubMed/NCBI
|
|
19
|
Rangel LB, Agarwal R, D'Souza T, Pizer ES,
Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR and Morin PJ:
Tight junction proteins claudin-3 and claudin-4 are frequently
overexpressed in ovarian cancer but not in ovarian cystadenomas.
Clin Cancer Res. 9:2567–2575. 2003.PubMed/NCBI
|
|
20
|
Jun KH, Kim JH, Jung JH, Choi HJ and Chin
HM: Expression of claudin-7 and loss of claudin-18 correlate with
poor prognosis in gastric cancer. Int J Surg. 12:156–162. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brokalaki EI, Weber F, Sotiropoulos GC,
Daoudaki M, Cicinnati VR and Beckebaum S: Claudin-7 expression in
hepatocellular carcinoma. Transplant Proc. 44:2737–2740. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh AB, Sharma A and Dhawan P: Claudin
family of proteins and cancer: An overview. J Oncol.
2010:5419572010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Resnick MB, Konkin T, Routhier J, Sabo E
and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage
II colonic cancer: A tissue microarray study. Mod Pathol.
18:511–518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ersoz S, Mungan S, Cobanoglu U, Turgutalp
H and Ozoran Y: Prognostic importance of claudin-1 and claudin-4
expression in colon carcinomas. Pathol Res Pract. 207:285–289.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Usami Y, Chiba H, Nakayama F, Ueda J,
Matsuda Y, Sawada N, Komori T, Ito A and Yokozaki H: Reduced
expression of claudin-7 correlates with invasion and metastasis in
squamous cell carcinoma of the esophagus. Hum Pathol. 37:569–577.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Al Moustafa AE, Alaoui-Jamali MA, Batist
G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R and
Foulkes WD: Identification of genes associated with head and neck
carcinogenesis by cDNA microarray comparison between matched
primary normal epithelial and squamous carcinoma cells. Oncogene.
21:2634–2640. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kominsky SL, Argani P, Korz D, Evron E,
Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S:
Loss of the tight junction protein claudin-7 correlates with
histological grade in both ductal carcinoma in situ and invasive
ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tokés AM, Kulka J, Paku S, Máthé M, Páska
C, Lódi C, Kiss A and Schaff Z: The expression of five different
claudins in invasive breast carcinomas: Comparison of pT1pN1 and
pT1pN0 tumors. Pathol Res Pract. 201:537–544. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hsueh C, Chang YS, Tseng NM, Liao CT,
Hsueh S, Chang JH, Wu IC and Chang KP: Expression pattern and
prognostic significance of claudins 1, 4 and 7 in nasopharyngeal
carcinoma. Hum Pathol. 41:944–950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tassi RA, Bignotti E, Falchetti M,
Ravanini M, Calza S, Ravaggi A, Bandiera E, Facchetti F, Pecorelli
S and Santin AD: Claudin-7 expression in human epithelial ovarian
cancer. Int J Gynecol Cancer. 18:1262–1271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rendón-Huerta E, Teresa F, Teresa GM,
Xochitl GS, Georgina AF, Veronica ZZ and Montaño LF: Distribution
and expression pattern of claudins 6, 7 and 9 in diffuse- and
intestinal-type gastric adenocarcinomas. J Gastrointest Cancer.
41:52–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakayama F, Semba S, Usami Y, Chiba H,
Sawada N and Yokozaki H: Hypermethylation-modulated downregulation
of claudin-7 expression promotes the progression of colorectal
carcinoma. Pathobiology. 75:177–185. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakagawa S, Miyoshi N, Ishii H, Mimori K,
Tanaka F, Sekimoto M, Doki Y and Mori M: Expression of CLDN1 in
colorectal cancer: A novel marker for prognosis. Int J Oncol.
39:791–796. 2011.PubMed/NCBI
|
